Shanghai Allist Pharmaceuticals Co Ltd Class A 688578
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥49.00
- Day Range
- ¥51.50–56.65
- 52-Week Range
- ¥32.25–68.87
- Bid/Ask
- ¥55.17 / ¥55.18
- Market Cap
- ¥24.83 Bil
- Volume/Avg
- 14.0 Mil / 4.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- 20.08
- Price/Sales
- 7.72
- Dividend Yield (Trailing)
- 1.33%
- Dividend Yield (Forward)
- 1.33%
- Total Yield
- 1.33%
Company Profile
Shanghai Allist Pharmaceuticals Co Ltd is an innovative drug company in the field of cancer treatment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,044
- Website
- http://www.allist.com.cn
Comparables
Valuation
|
Metric
|
688578
|
688739
|
688062
|
|---|---|---|---|
Price/Earnings (Normalized) | 20.08 | 28.96 | — |
Price/Book Value | 4.89 | 1.12 | 4.43 |
Price/Sales | 7.72 | 6.00 | 62.41 |
Price/Cash Flow | 19.06 | 16.98 | — |
Price/Earnings
688578
688739
688062
Financial Strength
|
Metric
|
688578
|
688739
|
688062
|
|---|---|---|---|
Quick Ratio | 7.39 | 17.26 | 1.53 |
Current Ratio | 7.97 | 18.49 | 1.78 |
Interest Coverage | 14,588.83 | 288.58 | −32.55 |
Quick Ratio
688578
688739
688062
Profitability
|
Metric
|
688578
|
688739
|
688062
|
|---|---|---|---|
Return on Assets (Normalized) | 24.62% | 3.14% | −24.26% |
Return on Equity (Normalized) | 26.90% | 3.29% | −41.90% |
Return on Invested Capital (Normalized) | 25.16% | 2.81% | −26.98% |
Return on Assets
688578
688739
688062
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Hxvtlyzbc | Cdjf | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Pkxlgkdw | Qtdlvp | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Dhlfywkmk | Xwrvcqg | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Lpzrzhtb | Jvvgrh | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Thgtbwjc | Wwbgn | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Zpgkqnz | Ptn | $28.1 Bil | |||
| Moderna Inc
MRNA
| Ftvchypd | Xmhr | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Vhdzspccb | Wvvts | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Wxdhgbc | Bjbbvbs | $13.4 Bil | |||
| Incyte Corp
INCY
| Zftvhssq | Kzgrxb | $12.7 Bil |
United States